KODATEF is not approved for use in the U.S. Demand for ARAKODA has been steadily growing in recent months as awareness and ...

Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25If approved, FILSPARI ...

Bayer is committed to advancing treatment in prostate cancer care, showcasing new analyses from its comprehensive clinical trial program for NUBEQA ® (darolutamide), which includes the ARANOTE, ...

Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25 If approved, FILSPARI could be the first and only approved medicine indicated ...

Understanding Sickle Cell Anemia and the Need for Early DiagnosisSickle cell anemia is a genetic blood disorder caused by a ...

New research at the University of Alberta may make it easier to diagnose serious diseases that disrupt the body's energy ...

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced additional follow-up ...

In October 2024, Novartis announced that based on its review of 48-week data from the Phase 3 MANIFEST-2 study, longer follow-up time is needed to determine the regulatory path for pelabresib in ...

Patients with CLE who have specific patient characteristics may have lower treatment response than patients who do not have these characteristics.

Luigi Mangione, accused of killing UnitedHealthcare CEO Brian Thompson, is using donations from supporters for his legal defense. Mangione, whose case has garnered significant public support, has ...